Long Covid

Debbie Abrahams Excerpts

Thursday 14th January 2021 Commons Chamber

[Debbie Abrahams (Oldham East and Saddleworth) (Lab)]

I, too, congratulate the hon. Member for Oxford West and Abingdon (Layla Moran) on securing this very important debate.

It is understandable that in the middle of the covid pandemic, the focus has been on primary prevention and managing the symptoms of those who become infected, but given that, as has already been said, the covid tracker survey suggests that more than 4 million people—about 12% of the population—have symptoms beyond the acute phase, which typically lasts just four weeks, with one in 10 having symptoms beyond 12 weeks, we also need to develop healthcare management responses that recognise that covid can have effects way beyond that acute phase. On top of that, we need an appropriate societal response to long covid, where people are supported during their illness and do not feel stigmatised. That is incredibly important.

I am pleased at the speed with which NICE has brought forward its guidelines for managing long covid. I particularly like the recommended holistic healthcare approach when assessing patients with symptoms between four weeks and 12 weeks, and after 12 weeks, with the emphasis on empathy and acknowledging the impact that the symptoms may be having on the patient’s day-to-day life, including their ability to work. However, I was surprised that there was no reference to immunology or immune therapies. I hope that we have learned from the mistakes made in how we prevent, treat and care for people suffering with chronic fatigue syndrome, also known as ME, and post-viral syndrome.

We know that covid-19, like other viruses, attacks multiple systems—respiratory, cardiovascular, nervous and gastrointestinal—as it attacks epithelial cells, which are distributed throughout the body, but our body’s ability to fight the virus depends on our immune system reacting appropriately and not overreacting. The British Society for Immunology and a number of other researchers have suggested that, in addition to long-term damage to multiple organs, the pain, muscle weakness, fatigue and even brain fog often associated with long covid may be due to inflammatory issues associated with our immune system itself rather than covid.

There is still so much we do not know about the virus, and I support calls for more research, as well as for the establishment of a disease register. More research is needed, and I am a strong advocate of evidence-based medicine, but it is important that we never let the perfect be the enemy of the good.

Finally, we must ensure, as I mentioned, that we have a societal response, not just a healthcare response. Working-age people in particular must be supported by their employers and by the Government, through the DWP. We must ensure that adequate support is provided to those with long covid who are not able to work. Stigmatising those with long covid should not be tolerated.